Skip to main content

Table 1 Baseline characteristics of CRVO-ME patients

From: Predictors of visual recovery in patients with macular edema secondary to central retinal vein occlusion after treatment with Conbercept

  CRVO-ME group
Numble 26
Age (years) 57.70 ± 12.91
Gender (F/M) 11/15
Race Asian
Duration between initial IVC and baseline (weeks) 4.58 ± 0.31
Number of IVC 3.08 ± 0.21
Fluorescein angiography (ischemic/nonischemic) 9/17
BCVA (logMAR) 1.00 ± 0.73
IOP (mmHg) 12.64 ± 2.13
Mean CST (μm) 747.58 ± 149.38
Mean MV (μm3) 747.58 ± 149.38
Mean PLT (μm) 58.96 ± 8.56
Mean ONLT (μm) 432.58 ± 45.24
Mean DEZ (μm) 2921.04 ± 536.37